Ilyang Pharamaceutical Co., Ltd. engages in the development and supply of pharmaceutical products primarily in Korea. The company offers nutrition supplements; drink products; ETC products; OEM products; and OTC products. It is also involved in the research and development of IY-GV50205 anti-cancer drug; IY-81149, a proton pump inhibitor, which is in multinational phase II b studies for the treatment of ulcers; Immunan for the treatment of anti-cancer chemotherapy side effects, and anti-cancer effects of antineo plastic drugs; testosterone that can be applied to fatigue, hypodynamia, melancholia, impotence, and anaphrodisia by congenital, adventitious, and senescent factors; lactobacillus, which is in clinical trials for constipation and diarrhea; and human growth hormones. The company also exports its products primarily to the United States and Europe. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharamaceutical Co., Ltd. in May 1991. Ilyang Pharamaceutical Co., Ltd. was founded in 1946 and is headquartered in Yongin, South Korea.
ilyang pharmaceutical co ltd
Phone: 82 33 1281 7851
Fax: 82 2 912 7875www.ilyang.co.kr
|No competitor information is available for 007570.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact ILYANG PHARMACEUTICAL CO LTD, please visit www.ilyang.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.